Eli Lilly Stock News & Updates
[WKN: 858560 | Symbol: LLY]
Medicare Covers Eli Lilly’s GLP-1 Medications Starting July! Morgan Stanley Raises Market Volume to $190 Billion!
Milestone in the USA: Starting July 2026, millions of seniors will gain access to GLP-1 medications...
Eli Lilly Strengthens GLP-1 Leadership Claim – Foundayo Surpasses Oral Semaglutide!
Eli Lilly is driving its growth through global dominance in the incretin drug market with Mounjaro...
Middle East conflict continues to weigh on DAX at the start of the week - Chemical stocks pressured after Goldman Sachs study - DEUTZ rises significantly after Warburg Buy rating - CTS Eventim under pressure following Exane downgrade - Eli Lilly surprises with positive study data on Retatrutide!
The DAX is showing somewhat larger declines in early trading due to the recent escalation in the Middle...
Eli Lilly Impresses with Study Data on Foundayo and Retatrutide – Stock Rises Over 4%!
The FDA approval for Foundayo as the first GLP-1 pill without fasting requirements is also convincing...
Escalation in the Middle East shakes the markets – US labor market report shatters forecasts and fuels interest rate fears – Alphabet closes $30 billion deal with SpaceX – Nvidia solidifies storage alliance with SK Hynix – Marvell Technology and Flex join the S&P 500 – Eli Lilly shines with new data on obesity drug – Lululemon in free fall after catastrophic outlook
After the recent trading day on Friday, June 5, 2026, US markets presented themselves in a deep red sell-off...
Eli Lilly: Three Strategic Acquisitions in the Vaccine Sector for Nearly 4 Billion USD!
Strategic Realignment Eli Lilly (LLY) is currently in an extremely comfortable financial position and...
Analysts' Top 5 Price Targets of May 22, 2026
Eli Lilly [US5324571083] Wolfe Research confirms Outperform rating with a price target of 1350 USD...
Analysts' Top 5 Price Targets of May 5, 2026
Pinterest [US72352L1061] TD Cowen reaffirms Buy rating and adjusts target price from $36 to $38 (57%...
Eli Lilly (LLY) – The pharmaceutical giant ignites new growth surge with weight-loss medications and significantly raises annual forecast!
Eli Lilly delivers a quarter to marvel at: Revenue +56% to $19.8 billion, EPS at $8.55 far exceeds expectations....
Wall Street and DAX on standby before Fed meeting – Oil prices rise due to ongoing Middle East blockade – Alphabet secures exclusive AI deal with Pentagon – Meta plans giant power supply from space – Eli Lilly revitalizes lucrative weight loss market with new pill – Init Innovation shines with million-dollar contract from Australia
Disappointing user numbers at AI pioneer OpenAI weigh on Nasdaq and burden US indices ahead of Fed...
Trump Reviews Iran’s Offer to Open Hormuz - Bank of Japan Warns of Inflation Surge Due to Iran Conflict - Google Opens Its AI for Secret Pentagon Operations - OpenAI Misses Growth Targets - Shell Accelerates Gas Business with ARC Acquisition - Eli Lilly Cementing its Pharmaceutical Dominance
The US stock market presented itself on Monday, April 27, 2026, in a tense, almost electrifying state....